Stock vs Stock Comparison

CVS Health Corporation vs Absci Corporation

CVS wins the Tale of the Tape 6–3.

CVS$91.37
ABSI$5.94

🏆 Tale of the Tape

63
CVSABSI
0.4%Profitability (Net Margin)-4113.7%
39.9xValuation (P/E)
2.5%Efficiency (ROIC)-46.9%
6/9Health (Piotroski F)2/9
2.3Safety (Altman Z)5.1
7.8%Growth (Rev YoY)-38.2%
0.47Risk (Sharpe 1Y)0.56
2.36xBalance Sheet (D/E)0.14x
5.08%FCF Yield-21.57%

Green = winner in each category. Higher is better except P/E (lower = cheaper).

Rolling Correlation

-0.031
252-Day Correlation
0.049
126-Day Correlation

Low correlation — excellent diversification pair.

Fundamentals

MetricCVSABSI
Market Cap$116.1B$1.1B
P/E Ratio39.9x
Forward P/E10.9x-10.6x
P/B1.50x6.10x
Dividend Yield2.92%
Beta0.592.38

Quantitative Metrics

MetricCVSABSI
DCF Fair Value$59.00
DCF Upside-24.4%
Piotroski F6/92/9
Altman Z2.275.11
Beneish M-2.58
FCF Yield5.08%-21.57%
Net Debt/EBITDA5.3x
ROIC2.5%-46.9%
WACC6.5%
ROIC – WACC-4.0pp
Gross Margin13.8%
Net Margin0.4%-4113.7%
Rev Growth YoY7.8%-38.2%
Sharpe (1Y)0.470.56
Max Drawdown 3Y-66.1%
FCF Payout Ratio44%

CVS Price

Loading chart...

ABSI Price

Loading chart...

ETF Exposure

CVS found in:

IYK4.29%
XLV2.22%
XHS2.21%
VHT1.71%
SPYD1.36%
DVY1.34%
ONEY1.12%
VFVA0.82%
VFMO0.57%
MGV0.53%
VYM0.43%
ONEO0.42%
SPYV0.41%
VTV0.41%
QUS0.34%
SCHV0.34%
VONV0.32%
IWD0.30%
SPY0.19%
RSP0.18%
ESGV0.18%
SPLG0.17%
IVV0.17%
VOO0.17%
SPTM0.17%
SCHX0.16%
VONE0.16%
SCHB0.15%
ITOT0.15%
VTI0.15%
URTH0.12%
ACWI0.10%
VT0.09%

ABSI found in:

ARKG4.81%
XBI0.32%

More Comparisons

Quant metrics computed from financial statements and 1,200+ trading days. Correlation is Pearson coefficient on daily log returns. Not investment advice.

CVS vs ABSI: Head-to-Head Analysis

CVS Health Corporation (CVS) and Absci Corporation (ABSI) represent two companies in the Healthcare sector. In our quantitative Tale of the Tape scoring, CVS leads 6–3 across nine fundamental and risk metrics including profitability, valuation, capital efficiency, and financial health.

In terms of capital efficiency, CVS generates a return on invested capital (ROIC) of 2.5% compared to ABSI's -46.9%. This suggests CVS is more effective at deploying capital to generate shareholder returns.

The 252-day rolling correlation between CVS and ABSI is -0.031, indicating low correlation, making them an effective diversification pair in a portfolio context.

CVS appears in 33 ETFs tracked by SecuritiesDB, while ABSI appears in 2 ETFs. Investors holding broad-market ETFs may already have indirect exposure to both stocks.

Frequently Asked Questions

Which stock is the better investment, CVS or ABSI?

Our quantitative analysis compares CVS and ABSI across nine fundamental dimensions. CVS wins the Tale of the Tape 6–3. However, stock selection depends on your individual risk tolerance, time horizon, and portfolio context. These metrics are computed from SEC filings and market data — they are not investment recommendations.

Are CVS and ABSI correlated?

The 252-day correlation between CVS and ABSI is -0.031. They have low correlation, offering good diversification.

How is the Tale of the Tape scored?

The Tale of the Tape compares both stocks across nine categories: profitability (net margin), valuation (P/E), efficiency (ROIC), health (Piotroski F-Score), safety (Altman Z-Score), growth (revenue YoY), risk (Sharpe ratio), leverage (debt-to-equity), and cash generation (FCF yield). The stock that wins more categories takes the overall score. Lower P/E and lower debt-to-equity count as wins.